Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyglandular autoimmune syndrome type II]

T Császár1, A Patakfalvi

  • 1Zala Megyei Onkormányzat Kórház-Rendelöintézete, I. Belgyógyászat, Zalaegerszeg.

Orvosi Hetilap
|July 18, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cyclosporin-A therapy in autoimmune diseases].

Orvosi hetilap·1996
Same author

[Differential diagnostic problems in Lyme disease (Borrelia infection resulting in acute exogenous psychosis)].

Orvosi hetilap·1994
Same author

[Smoldering myeloma].

Orvosi hetilap·1993
Same author

[Successful treatment of hemorrhaging necrotizing pancreatitis with peritoneal dialysis].

Orvosi hetilap·1993
Same author

[Successful treatment of hyperthyroidism simulating acute abdomen and psychosis].

Orvosi hetilap·1992
Same author

Treatment of polyglandular autoimmune syndrome with cyclosporin-A.

Acta medica Hungarica·1992
Same journal

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same journal

[Long-COVID syndrome and lung-specific abnormalities following COVID-19].

Orvosi hetilap·2026
Same journal

[Validation of the Vaccination Attitudes Examination (VAX) scale in Hungary].

Orvosi hetilap·2026
Same journal

Orvosi hetilap·2026
Same journal

[The Hungarian short version and psychometric properties of the Activities-specific Balance Confidence Scale for assessing fall risk].

Orvosi hetilap·2026
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
See all related articles

A rare polyglandular autoimmune syndrome type II developed in a young woman after a viral infection, leading to severe immunthrombocytopenia. Cyclosporin therapy achieved total remission, highlighting its potential in treating this rare condition.

Area of Science:

  • Endocrinology
  • Immunology
  • Hematology

Background:

  • Polyglandular autoimmune syndrome type II (PAS II) is a rare autoimmune disorder affecting multiple endocrine glands.
  • Viral infections can sometimes trigger autoimmune responses, leading to complex clinical presentations.

Observation:

  • A young woman developed progressive endocrine disorders over four years following a viral infection.
  • She subsequently developed severe immunthrombocytopenia, a condition characterized by low platelet counts due to autoimmune processes.

Findings:

  • The patient was diagnosed with the rare polyglandular autoimmune syndrome type II.
  • Initial treatment with steroid therapy proved insufficient, and severe bleeding due to thrombocytopenia necessitated further intervention.
  • Cyclosporin therapy was initiated and resulted in a complete remission of the syndrome.

Related Experiment Videos

Implications:

  • This case highlights the potential for viral infections to precipitate rare autoimmune endocrine disorders.
  • Cyclosporin therapy demonstrated significant efficacy in achieving remission for this patient with PAS II and severe immunthrombocytopenia.
  • The successful treatment underscores the importance of considering novel therapeutic approaches for rare autoimmune conditions.